Methods A total of 560 patients (28 lean, 174 overweight, 229 obese, 89 severely obese, 40
morbidly obese) were included. Diagnostic performances and optimal cut-off values for FIB …

Background Non-invasive scores, such as the non-alcoholic fatty liver disease (NAFLD)
Fibrosis Score (NFS), are increasingly used for liver fibrosis assessment in patients with …

Abstract Aims Fibrosis‐4 index (FIB‐4) and non‐alcoholic fatty liver disease (NAFLD)
fibrosis score (NFS) are the two most widely used non‐invasive tools for screening of …

BACKGROUND Non-invasive fibrosis scores are not yet validated in the newly defined
metabolic associated fatty liver disease (MAFLD). AIM To evaluate the diagnostic …

Methods The NHANES 2017-2018 datasets were used to compare the performances of
different noninvasive fibrosis scores in MAFLD, including the aspartate aminotransferase …

BACKGROUND Identifying hepatic fibrosis is crucial for nonalcoholic fatty liver disease
(NAFLD) management. The fibrosis-8 (FIB-8) score, recently developed by incorporating …

Context Guidelines recommend blood-based fibrosis biomarkers to identify advanced
nonalcoholic fatty liver disease (NAFLD), which is particularly prevalent in patients with …

IMPORTANCE The diagnostic performance of the fibrosis-4 index (FIB-4) and nonalcoholic
fatty liver disease (NAFLD) fibrosis score (NFS) for advanced fibrosis in lean patients with …

Background Early screening may prevent fibrosis progression in metabolic‐associated fatty
liver disease (MAFLD). Aims We developed and validated MAFLD fibrosis score (MFS) for …

Aim Non‐alcoholic fatty liver disease (NAFLD)‐related advanced hepatic fibrosis is
associated with liver and cardiovascular morbidity and mortality. This study aims to compare …